RMD announced yesterday the $1.45bn purchase of Germanys healthcare platform MediFox Dan, a leader in Out-of-Hospital software solutions. We like the general direction the company is moving with this being its 3rd and largest acquisition in the software space although the expansion into Europe may prove a slow but steady process. The deal is to be funded by existing credit facilities which is encouraging as a capital raise won’t be required later in the year.
- Technically RMD will look really good into fresh 12-month lows under $27 and we may tweak our position higher into such a move.